3 | SEC Filings Hub

Filing metadata

Accession number: 0001641172-25-014434
Form type: Form 3
Filer: Telomir Pharmaceuticals, Inc.
CIK: CIK 1971532
Filed: Jun 10, 2025
Reporting period: May 15, 2025
Description: Initial ownership

Documents

0001641172-25-014434-index.htm

Complete submission

0001641172-25-014434.txt

directory listing

Filed by

Telomir Pharmaceuticals, Inc.